MRD / Regn No. : 20240000358 Date : 20/07/2026
Patient Name : Sridhar Raghavan Age & Gender : 47 Yrs. / Male
Contact No. : 9444627921 UHID :
Ht / Wt / BMI : 172 / 76.7 / 25.93 BP S / BP D : /
Allergies : NKA Referred By :
   
Problem List : TYPE 2 DM (16/Apr/2024) | OBESITY (16/Apr/2014) | DYSLIPIDEMIA (16/Apr/2024) | HYPERTENSION (16/Apr/2011) | IMIGLEMIN INTOLERANCE (24/Apr/2025) |
Subjective : RARE DYSESTHESIA,POSTURAL DIZZINESS RESOLVED
Objective : NONE
Analysis : OBESITY,DYSLIPIDEMIIA,TYPE 2 DM IMPROVING CONTROL,GLUCOSES IN THE PREDIABETES RANGE,MASLD F0S0,PHARMACOLOGIC REMISSION
Plan : CONTINUE CURRENT MEDICATIONS,SEE ME IN 3 MONTHS WITH TESTING  
Salient Investigations : FASTING PLASMA GLUCOSE (FPG): 79 mg/dL | GLYCOSYLATED HEMOGLOBIN (HBA1C): 5.2 % | POST PRANDIAL GLUCOSE (2HPP): 62 mg/dL
S# Generic (Trade) Name Route Dosage Usage Duration
1 TELMISARTAN 40 MG
ERITEL 40 MG
0-0-1 AT BEDTIME
TILL NEXT VISIT
MAY CAUSE HIGH POTASSIUM
2 TABLET DAPAGLIFLOZIN 10 MG
FORXIGA
Medicine For DIABETES OBESITY HEART AND KIDNEY PROTECTION
PO 1-0-0 BEFORE FOOD
TILL NEXT VISIT
MAY CAUSE GENITOURINARY INFECTIONS
3 ROSUVASTATIN 10 MG
ROSEDAY 10 MG
Medicine For CHOLESTEROL
PO 0-0-1 AT BEDTIME
TILL NEXT VISIT
MAY CAUSE FATIGUE AND MUSCLE PAIN
4 INJECTION SEMAGLUTIDE 1 MG
OZEMPIC
Medicine For OBESITY DIABETES
SQ ONCE A WEEK AS DIRECTED NO RELATION TO FOOD
TILL NEXT VISIT
MAY CAUSE NAUSEA VOMITING
       
Refill : 0 / Substitution:    
Education :
Next Visit : 18/Oct/2026
Tests Suggested For Next Visit : FBS 2HPP HBA1C
   
   

Dr. Krishna G Seshadri
Sr. Consultant Endocrinology Diabetes and Metabolism
Tamil Nadu / 48748 HPRID: 71-0638-2075-7542

This is a Computer generated Prescription

Powered By: